Immunogenicity and Protective Efficacy of an mRNA Vaccine Targeting HSV-2 UL41 in Mice
Our study suggests that the UL41 mRNA vaccine may provide effective protection against HSV-2-related diseases and holds promise as a potential mRNA vaccine candidate.
Authors
- Yi‐Qun Kuang (ORCID: https://orcid.org/0000-0002-1452-4388)
- Tangwei Mou (ORCID: https://orcid.org/0009-0003-5798-045X)
- Yu Zhao (ORCID: https://orcid.org/0000-0002-9197-274X)
- Shaoyou Li (ORCID: https://orcid.org/0000-0001-9318-5910)
- Kai-Cheng Gao
- Jie Jia (ORCID: https://orcid.org/0000-0003-3238-1947)
Institutions
- Kunming Medical University (CN)
- First Affiliated Hospital of Kunming Medical University (CN)
Publication Details
- Journal
- Vaccines
- Published
- 2025-03-05
- DOI
- https://doi.org/10.3390/vaccines13030271
- Citations
- 2
- Primary Topic
- Herpesvirus Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.71
Funders
- National Natural Science Foundation of China